Brief: Enorama Pharma Q4 Operating Loss Widens To SEK 8.7 Mln
17/02/2021 08:05
Feb 17 (Reuters) - Enorama Pharma AB ERMA.ST :
* Q4 NET SALES SEK 55,000 VERSUS SEK 0.7 MILLION YEAR AGO
* Q4 OPERATING LOSS SEK 8.7 MILLION VERSUS LOSS SEK 7.0
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr9R7Vtx
Further company coverage: ERMA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO